# Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program

> **NCT04650269** · PHASE4 · COMPLETED · sponsor: **University of Miami** · enrollment: 27 (actual)

## Conditions studied

- Harm Reduction
- HIV Infections
- Drug Use

## Interventions

- **DRUG:** Biktarvy 50Mg-200Mg-25Mg Tablet
- **OTHER:** HIV care

## Key facts

- **NCT ID:** NCT04650269
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-04
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04650269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04650269, "Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04650269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*